 In an announcement on Monday, Siemens Healthineers AG ETR: SHL said that its net profit in the fiscal first quarter posted a 44 annualised growth to 384.80 million. The company said that its rapid antigen tests saw robust demand in recent months as the new variant of the Coronavirus pandemic wreaked havoc in Germany. 